| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.013 | 1 |